Dr Reddy’s to launch lansoprazole capsules in US

New Delhi, Oct 16 (IANS) Dr Reddy’s Laboratories Saturday said it will launch its lansoprazole delayed-release capsules in the US market very soon, after receiving approval from the US Food and Drug Administration (FDA).

The approval was received Friday, the firm said.

The firm’s launch preparations are complete and the shipments will commence shortly, it said in a regulatory filing.

Dr. Reddy’s Lansoprazole delayed-release capsules are available in bottles of 30 and 90 counts in 15 mg and 90 and 500 counts in 30 mg.

Leave a Reply

Your email address will not be published. Required fields are marked *